References

Citations

1. Shy ME (2008). Guillain-Barré syndrome section of Peripheral neuropathies. In L Goldman, D Ausiello, eds., Cecil Textbook of Medicine, 23rd ed., pp. 2802–2816. Philadelphia: Saunders Elsevier.

2. Centers for Disease Control and Prevention (2007). Inactivated influenza vaccine: What you need to know. Vaccine Information Statement. Department of Health and Human Services. Available online: http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-flu.pdf.

3. Juurlink DN, et al. (2006). Guillain-Barré syndrome after influenza vaccination in adults: A population-based study. Archives of Internal Medicine, 166(20): 2217–2221.

4. Vajsar J, et al. (2003). Long-term outcome in children with Guillain-Barré syndrome. Journal of Pediatrics, 142: 305–309.

5. Hughes RAC, et al. (2003). Practice parameter: Immunotherapy for Guillain-Barré syndrome. Neurology, 61: 736–740.

6. Chiò A, et al. (2003). Guillain-Barré syndrome: A prospective, population-based incidence and outcome survey. Neurology, 60(7): 1146–1150.

7. Ropper AH, Brown RH (2005). Guillain-Barré syndrome (Landry-Guillain-Barré-Strohl syndrome, acute inflammatory polyneuropathy, AIDP) section of Diseases of the peripheral nerves. In Adams and Victor's Principles of Neurology, 8th ed., pp. 1110–1177. New York: McGraw-Hill.

Other Works Consulted

• Hughes RAC, et al. (2006). Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

• Lovitt S, Harati Y (2003). Guillaine-Barré syndrome. In RW Evans, ed., Saunders Manual of Neurologic Practice, chap. 2, pp. 572–575. Philadelphia: Saunders.

• Raphaël JC, et al. (2002). Plasma exchange for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews (2). Oxford: Update Software.